Review of Cases of E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Brief Review of the Literature

Since the appearance of the E-Cigarette in the early 2000s, its industry, popularity, and prevalence have risen dramatically. In the past, E-Cigarette use with the vaping of nicotine or cannabis products had been associated with a few reported cases of lung injury. However, in 2019, thousands of cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Essa, Amr, Macaraeg, Jeffrey, Jagan, Nikhil, Kwon, Daniel, Randhawa, Saboor, Kruse, Matthew, Thomas, Stanley, Velagapudi, Manasa, Horne, John, Narechania, Shraddha, Kaster, Michael, Valenta, Carrie, Sahasranaman, Venketraman, Moore, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313101/
https://www.ncbi.nlm.nih.gov/pubmed/32607271
http://dx.doi.org/10.1155/2020/1090629
Descripción
Sumario:Since the appearance of the E-Cigarette in the early 2000s, its industry, popularity, and prevalence have risen dramatically. In the past, E-Cigarette use with the vaping of nicotine or cannabis products had been associated with a few reported cases of lung injury. However, in 2019, thousands of cases of E-Cigarette or vaping product use-associated lung injury (EVALI) were reported in the United States. Evidence linked this outbreak with vaping of tetrahydrocannabinol (THC). We report two confirmed cases of EVALI and their associated clinical, radiologic, and pathologic features. This report supports the growing body of information regarding EVALI. It also discusses various substances, particularly vitamin E acetate, which has been suggested as a causative agent.

Ejemplares similares